Inhibrx Biosciences, Inc. Common Stock When Issued
Inhibrx Biosciences, Inc. Common Stock When Issued (INXBV) Stock Overview
Explore Inhibrx Biosciences, Inc. Common Stock When Issued’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
198.2M
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
N/A
INXBV Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Inhibrx Biosciences, Inc. Common Stock When Issued (INXBV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 198.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.